[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100598796":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":10,"locations":23,"responsibleParty":51,"collaborators":53,"id":57,"slug":10,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":62,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":10,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":10,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"University of Southern California","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Patients complete a questionnaire and have their medical records reviewed on study.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Non-Interventional Study","Non-interventional study",[9],[20],{"name":21,"affiliation":5,"role":22},"Jacob Comeaux","PRINCIPAL_INVESTIGATOR",[24,43],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Los Angeles General Medical Center","RECRUITING","Los Angeles","California","90033","United States",{"type":32,"coordinates":33},"Point",[34,35],-118.24368,34.05223,{"lat":35,"lon":34},[38,42],{"name":21,"role":39,"phone":40,"phoneExt":10,"email":41},"CONTACT","323-865-0474","Jacob.Comeaux@med.usc.edu",{"name":21,"role":22,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":26,"city":27,"state":28,"zip":29,"country":30,"cosmosGeoPoint":45,"geoPoint":47,"contacts":48},"USC \u002F Norris Comprehensive Cancer Center",{"type":32,"coordinates":46},[34,35],{"lat":35,"lon":34},[49,50],{"name":21,"role":39,"phone":40,"phoneExt":10,"email":41},{"name":21,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":52,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[54],{"name":55,"class":56},"National Cancer Institute (NCI)","NIH","100598796",false,"NCT07076147","Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer","Inclusion Criteria:\n\n* \\* \\>= 30 years\n\n  * =\\\u003C 75 years\n  * Women with either:\n\n    * Genetic test results showing moderately increased breast cancer risk due to a pathogenic\u002Flikely pathogenic variant in ATM, CHEK2, BARD1, RAD51C, or RAD51D (Mutation carrier group) OR\n    * Calculated lifetime breast cancer risk estimates between 20% and 40% according to the Tyrer-Cuzick V8.0B empiric risk model (Empiric risk group)\n  * Patients provided breast cancer risk assessments by genetic counselors at USC Norris or LA General Hospital beginning in 2021 and at least 12 months ago\n  * Women recommended to undergo annual breast MRI and\u002For annual mammogram beginning at the time of their genetic counseling risk assessment\n  * English or Spanish speaking patients\n\nExclusion Criteria:\n\n* \\* History of breast cancer before genetic counseling at University of Southern California (USC)\n\n  * Any metastatic cancer diagnosis at time of genetic counseling risk assessment\n  * Deceased\n  * Patient underwent a risk reducing mastectomy before their genetic counseling risk assessment",true,"FEMALE","30 Years","75 Years",{"count":67,"type":68},150,"ESTIMATED","OBSERVATIONAL","This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.",[72],"Breast Carcinoma","2026-05-29",{"date":75,"type":76},"2026-06-01","ACTUAL",{"date":78,"type":76},"2025-06-02",{"date":80,"type":68},"2028-06-02",{"name":5,"class":6},2]